Pillstats
Rx only · Tablet, Delayed Release · Oral

Doxycycline Hyclate

Brands: Doryx Mpc · Doxycycline Hyclate

6 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US20 NDCs
6 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)3640
US makers6 labelers
Packages52
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 13 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$1.26$2.51$3.77$5.02Jan 2025Mar 2026Jul 2026
$3.529
Latest avg · Jul 22, 2026
+212%
Since Jan 22, 2025
6
Active US suppliers
73%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

5301.1K1.6K2.1K2025 Q12025 Q22025 Q32025 Q42026 Q1
1.1K
Rx · 2026 Q1
31K
Units dispensed
-38%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it6 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Alembic Pharmaceuticals Limitedunknown28SUPPLYING
Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.unknown10SUPPLYING
Solco Healthcare US, LLCunknown7SUPPLYING
Mayne Pharma Commercial LLCunknown4SUPPLYING
Actavis Pharma, Inc.unknown2SUPPLYING
Sonoma Pharmaceuticals, Inc.unknown1SUPPLYING

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.